The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety profile consistent with similar ADCs and initial...
Vous n'êtes pas connecté
Radiopharm Theranostics has boosted its stake in a US-based joint venture with the University of Texas MD Anderson Cancer Center to 75 per cent after promising early results in a wide range of tumour therapies.
The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety profile consistent with similar ADCs and initial...
A new tool for monitoring immune health patterns over time has revealed how a pair of checkpoint inhibitor therapies work together to recruit new...
., has acquired a portion of Toronto’s iconic former Maple Leaf Gardens building as part of a three-property portfolio it is buying into in a 50/50...
Researchers at University of California San Diego have published new guidelines that could help scientists significantly improve their results when...
Researchers at University of California San Diego have published new guidelines that could help scientists significantly improve their results when...
Santos and its joint venture partners have agreed to give Timor Leste a stake in a long-running gas venture to keep plans for a carbon capture hub...
A new study reveals a potential breakthrough in combating aggressive prostate cancer Researchers from Flinders University and the University of South...
Competitive: Cooper University Health Care (US): About us At MD Anderson @ Cooper our commitment to providing extraordinary health care begins with...
Competitive: Cooper University Health Care (US): About us At MD Anderson @ Cooper our commitment to providing extraordinary health care begins with...
An experimental mRNA cancer vaccine shows promising results in a Phase 1 trial, potentially offering new hope for advanced-stage cancer patients.